Antibodies against OX40 and uses thereof
US9644032B2 · kind B2 · utility
8Cited by
17References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 26, 2016 |
| Grant date | May 9, 2017 |
| Priority date | — |
| Expiry date | May 26, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70514
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are antibodies, or antigen binding portions thereof, that bind to OX40. Also provided are uses of these proteins in therapeutic applications, such as in the treatment of cancer. Further provided are cells that produce the antibodies, polynucleotides encoding the heavy and/or light chain variable region of the antibodies, and vectors comprising the polynucleotides encoding the heavy and/or light chain variable region of the antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.